FNG II - 43857-0081-1 - (Echinacea, Hydrastis Canadensis, Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Iodium, Adrenalinum)

Alphabetical Index


Drug Information of FNG II

Product NDC: 43857-0081
Proprietary Name: FNG II
Non Proprietary Name: Echinacea, Hydrastis Canadensis, Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Iodium, Adrenalinum
Active Ingredient(s): 12; 3; 8; 3; 6; 3; 30; 3; 12; 30; 30; 8; 8; 8; 3    [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL & nbsp;   Echinacea, Hydrastis Canadensis, Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Iodium, Adrenalinum
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of FNG II

Product NDC: 43857-0081
Labeler Name: BioActive Nutritional
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 20120927

Package Information of FNG II

Package NDC: 43857-0081-1
Package Description: 30 mL in 1 BOTTLE, DROPPER (43857-0081-1)

NDC Information of FNG II

NDC Code 43857-0081-1
Proprietary Name FNG II
Package Description 30 mL in 1 BOTTLE, DROPPER (43857-0081-1)
Product NDC 43857-0081
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Echinacea, Hydrastis Canadensis, Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Iodium, Adrenalinum
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20120927
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name BioActive Nutritional
Substance Name CANDIDA ALBICANS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GOLDENSEAL; IODINE; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; NASTURTIUM OFFICINALE; PHOSPHORAMIDIC ACID; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SILVER; SUS SCROFA THYMUS; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK
Strength Number 12; 3; 8; 3; 6; 3; 30; 3; 12; 30; 30; 8; 8; 8; 3
Strength Unit [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmaceutical Classes Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE]

Complete Information of FNG II


General Information